Nimotuzumab Combined With Radiotherapy for Older Patients With Esophageal Cancer: a Single, Non-control Phase II Clinical Trial
Latest Information Update: 27 Sep 2023
At a glance
- Drugs Nimotuzumab (Primary)
- Indications Oesophageal cancer
- Focus Adverse reactions
- 02 Feb 2021 Status changed from active, no longer recruiting to completed.
- 04 Nov 2011 New trial record